• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Regulatory press release

Marcel Warntjes resigns from the Board of Directors of SyntheticMR AB (publ)

SyntheticMR
Download the release

22 November 2025

SyntheticMR AB (publ) announces today that Marcel Warntjes, at his own request, has decided to resign from his position as a member of the Board of Directors with immediate effect. Marcel Warntjes will remain a member of the Nomination Committee, in his capacity as one of the company's largest shareholders.

"Having founded SyntheticMR almost twenty years ago, I believe the time is now right for me to step down from my role on the Board. The company is entering a very exciting phase in which the continued roll-out of SyMRI 3D, together with the combined technologies of Combinostics and SyntheticMR, has created a strong platform for sustained leadership in the objective quantification of MRI examinations. With CEO Lena Åredal in place, I am confident that the company is well positioned to take the next step, while I look forward to dedicating more time to research," says Marcel Warntjes.

The Board of Directors would like to express its sincere gratitude to Marcel for his extensive and long-standing contributions to the company's development in several key roles over nearly two decades.

For further information, please contact:
Gisli Hennermark, Chairman of the Board, tel. +46 70-420 83 00
Lena Åredal, CEO, tel. +46 76-770 99 08

This disclosure contains information that SyntheticMR AB is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person, on 22-11-2025 15:54 CET.